Molecular basis of T-cell differentiation

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 64, Issue , 1999, Pages 563-571

  Flavell, R A ^a   Li, B ^a   Dong, C ^a   Lu, H T ^a   Yang, D D ^a,b   Enslen, H ^c   Tournier, C ^c   Whitmarsh, A ^c   Wysk, M ^c   Conze, D ^d   Rincon, M ^d   Davis, R J ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE; CALCINEURIN; GAMMA INTERFERON; GROWTH FACTOR; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 9; IONOMYCIN; LYMPHOTOXIN; MITOGEN ACTIVATED PROTEIN KINASE 14; MITOGEN ACTIVATED PROTEIN KINASE P38; SCAFFOLD PROTEIN; SYNAPTOPHYSIN; TYROSINE; ZINC FINGER PROTEIN;

CONFERENCE PAPER; ENZYME ACTIVATION; HUMAN; LYMPHOCYTE DIFFERENTIATION; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH1 CELL; TRANSCRIPTION REGULATION; ANTIBODY RESPONSE; ARTICLE; ATYPICAL MYCOBACTERIOSIS; CD8+ T LYMPHOCYTE; CELL CYCLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENVIRONMENTAL STRESS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATION; LUCIFERASE ASSAY; MORBIDITY; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; UPREGULATION;

EID: 0033504733     PISSN: 00917451     EISSN: None     Source Type: Book Series    
DOI: 10.1101/sqb.1999.64.563     Document Type: Conference Paper

References (55)

1. Aune T.M., Penix L.A., Rincón M., and Flavell R.A. 1997. Differential transcription directed by discrete γ interferon promoter elements in naive and memory (effector) CD4 T cells and CDS T cells Mol. Cell. Biol. 17: 199.
2. Azuma M., Ito D., Yagita H., Okumura K., Phillips J.H., Lanier L., and Somoza C. 1993. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366: 76.
3. Bretscher P.A., Wei G., Menon J.N., and Bielefeldt-Ohmann H. 1992. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science 257: 539.
4. + T cells. J. Exp. Med. 182: 1591.
5. Croft M., Bradley L.M., and Swain S.L. 1994. Naive versus memory CD4 T cell response to antigen. J. Immunol. 152: 2675.
6. Dong C., Yang D.D., Wysk M., Whitmarsh A.J., Davis R.J., and Flavell R.A. 1998. Defective T cell differentiation in the absence of Jnk1. Science 282: 2092.
7. Fanger G.R., Gerwins P., Widmann C., Jarpe M.B., and Johnson G.L. 1997. MEKKs, GCKs, MLKs, PAKs, TAKs, and tpls: Upstream regulators of the c-Jun amino-terminal kinases? Curr. Opin. Genet. Dev. 7: 67.
8. Freeman G.J., Freedman A.S., Segil J.M., Lee G., Whitman J.L., and Nadler L.M. 1989. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J. Immunol. 143: 2714.
9. Freeman G.J., Bordello F., Hodes R.J., Reiser H., Gribben J.G., Ng J.W., Kim J., Goldberg J.M., Hathcock K., and Laszlo G. 1993. Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production. J. Exp. Med. 178: 2185.
10. Ho I.-C., Lo D., and Glimcher L.H. 1998. c-maf promotes T helper cell type 2 (Th2) and attenuates Th1 differentiation by both interleukin 4-dependent and -independent mechanisms. J. Exp. Med. 188: 1859.
11. Ho I.-C., Hodge M.R., Rooney J.W., and Glimcher L.H. 1996. The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell 85: 973.
12. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260: 547.
13. Hubank M. and Schatz D.G. 1994. Identifying differences in mRNA expression by representational difference analysis of cDNA. Nucleic Acids Res. 22: 5640.
14. Ip Y.T. and Davis R.J. 1998. Signal transduction by the c-Jun N-terminal kinase (JNK)-From inflammation to Drosophila development. Curr. Opin. Cell Biol. 10: 205.
15. Kamogawa Y., Minasi L.-A.E., Carding S., Bottomly K., and Flavell R.A. 1993. The relationship of IL-4 and IFNγ-producing T cells studied by lineage ablation of IL-4-producing cells. Cell 75: 985.
16. Kaplan M.H., Schindler U., Smiley S.T., and Grusby N.J. 1996a. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4: 313.
17. Kaplan M.H., Sun Y.-L., Hoey T., and Grusby M.J. 1996b. Impaired IL-12 responses and enhanced development of Th2 cells in Stat-4 deficient mice. Nature 382: 174.
18. Kuchroo V.K., Das M. P., Brown J.A., Ranger A.M., Zamvil S.S., Sobel R.A., Weiner H.L., Nabavi N., and Glimcher L.H. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy. Cell 80: 707.
19. Lee H.J., O'Garra A., Arai K.-I., and Arai N. 1998. Characterization of cis-regulatory elements and nuclear factors conferring Th2-specifc expression of the IL-5 gene. J. Immunol. 160: 2342.
20. Le Gros G., Ben-Sasson S.Z., Seder R., Finkelman F.D., and Paul W.E. 1990. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4 producing cells. J. Exp. Med. 172: 921.
21. Lenschow D.J., Ho S.C., Sattar H., Rhee L., Gray G., Nabavi N., Herold K.C., and Bluestone J.A. 1995. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med. 181: 1145.
22. Li B., Tournier C., Davis R.J., and Flavell R.A. 1999. Regulation of T helper cell differentiation by the transcription factor JunB. EMBO J. 19: 420.
23. Linsley P.S. and Ledbetter J.A. 1993. The role of the CD28 receptor during T cell responses. Annu. Rev. Immunol. 11: 191.
24. Linsley P.S., Brady W., Grosmaire L., Aruffo A., Damle N.K., and Ledbetter J.A. 1991. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 173: 721.
25. Lisitsyn N., Lisitsyn N., and Wigler M. 1993. Cloning the differences between two complex genomes. Science 259: 946.
26. Lu H.-T., Yang D.D., Wysk M., Gatti E., Mellman I., Davis R.J., and Flavell R.A. 1999. Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (MkkS)-deficient mice. EMBO J. 18: 1845.
27. Mueller D.L., Jenkins M.K., and Schwartz R.H. 1989. Clonal expansion vs. functional clonal inactivation: A costimulatory pathway determines the outcome of T cell receptor occupancy. Annu. Rev. Immunol. 7: 445.
28. Murphy E., Shibuya K., Hosken N., Openshaw P., Maino V., Davis K., Murphy K., and O'Garra A. 1996. Reversibility of T helper 1 and 2 populations is lost after long-term stimulation. J. Exp. Med. 183: 901.
29. + T cells. J. Immunol. 158: 1085.
30. Nishina H., Fischer K.D., Radvanyl L., Shahinian A., Hakem R., Roble E.A., Bernstein A., Mak T.W., Woodgett J.R., and Penninger J.M. 1997. Stress-signaling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CD3. Nature 385: 350.
31. Paul W.E. and Seder R.A. 1994. Lymphocyte response and cytokines. Cell 76: 241.
32. Penix L., Weaver W.M., Pang Y., Young H.A., and Wilson C.B. 1993. Two essential regulatory elements in the human interferon gamma promoter confer activation specific expression in T cells. J. Exp. Med. 178: 1483.
33. Penix L.A., Sweetser M.T., Weaver W.M., Hoey T., Hoeffler J.P., Kerpolla T.K., and Wilson C.B. 1996. The proximal regulatory element of the interferon-γ promoter mediates selective expression in T cells. J. Biol. Chem. 271: 31964.
34. Pfeiffer C., Stein J., Southwood S., Keterlaar H., Sette A., and Bottomly K. 1995. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J. Exp. Med. 181: 1569.
35. Ranganath S., Ouyang W., Bhattarcharya D., Sha W.C., Grupe A., Peltz G., and Murphy K.M. 1998. GATA-3 dependent enhancer activity in IL-4 gene regulation. J. Immunol. 161: 3822.
36. + Th2 cells but not in Th1 cells. Mpl. Cell. Biol. 17: 1522.
37. + T cells. J. Exp. Med. 185: 461.
38. + T cells to effector Th1 and Th2 cells. Genes Funct. 1: 51.
39. Rincón M., Enslen H., Raingeaud J., Recht M., Zapton T., Su M.S.-S., Penix L.A., Davis R.J., and Flavell R.A. 1998. Interferon-γ expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway. EMBO J. 17: 2817.
40. Robinson D., Shibuya K., Mui A., Zonin F., Murphy E., Sana T., Hartley S.B., Menon S., Kastelein R., Bazan F., and O'Garra A. 1997. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-γ production and activates IRAK and NFκB. Immunity 7: 571.
41. + T cells to enhance priming for IFNγ production and diminish IL-4 inhibition of such priming. Proc. Natl. Acad. Sci. 90: 10188.
42. Shimoda K., van Deursen J., Sangster M.Y., Sarawar S.R., Carson R.T., Tripp R.A., Chu C., Quelle F.W., Nosaka T., Vignali D.A., Doherty P.C., Grosveld G., Paul W.E., and Ihle J.N. 1996. Lack of IL4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380:630.
43. Sprent J. 1993. Lifespans of naive, memory and effector lymphocytes. Curr. Opin. Immunol. 5: 433.
44. Swain S.L., Weinberg A.D., English M., and Huston G. 1990. IL-4 directs the development of Th2-like helper effectors. J. Immunol. 145: 3796.
45. Takeda K., Tanaka T., Shi W., Matsumoto M., Minami M., Kashiwamura S.-I., Nakanishi K., Yoshida N., Kishimoto T., and Akira S. 1996. Essential role of Stato in IL-4 signaling. Nature 380: 627.
46. Thierfelder W.E., van Deursen J.M., Yamamoto K., Tripp R.A., Sarawar S.R., Carson R.T., Sangster M.Y., Vignali D.A., Doherty P.C., Grosveld C., and Ihle J.N. 1996. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382: 171.
47. Tough D.F. and Sprent J. 1995. Lifespan of lymphocytes. Immunol. Res. 14: 1.
48. Wenner C.A., Szabo S.J., and Murphy K.M. 1997. Identification of IL-4 promoter elements conferring Th2-restricted expression during T helper cell subset development. J. Immunol. 158: 765.
49. Whitmarsh A.J. and Davis R.J. 1996. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J. Mol. Med. 74: 589.
50. + T cells to Th1 cells requires MAP kinase JNK2. Immunity 9: 575.
51. 2-terminal kinase activation and defects in AP-1 transcriptional activity. Proc. Natl. Acad. Sci. 94: 3004.
52. Yang D.D., Kuan C.-Y., Whitmarsh A.J., Rincón M., Zheng T.S., Davis R.J., Rakic P., and Flavell R.A. 1997b. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389: 865.
53. Zhang D.H., Cohn L., Ray P., Bottomly K., and Ray A. 1997. Transcriptional factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J. Biol. Chem. 272: 21597.
54. Zhang F., Wang D.Z., Boothby M., Penix L.A., Flavell R.A., and Aune T.M. 1998. Regulation of the activity of IFN-γpromoter elements during Th cell differentiation. J. Immunol. 161: 6105.
55. + T cells. Cell 89: 587.